This is actually great news! Clearly the company understands that in order to penetrate international markets they need to seek an external commercialisation team that already has knowledge and presence within the markets of interest to PSY. This to me is a step in the right direction. It's no longer about product development. It's about forming the right relationships and making deals, this is not Jason's expertise, hence the change. A great strategic move imo.
Losing the plot, page-14
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HYD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.796M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1527025 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 160554 | 4 |
View Market Depth
| Last trade - 16.12pm 06/09/2024 (20 minute delay) ? |
| HYD (ASX) Chart |
Day chart unavailable